Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

538
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
538
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

6.5K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
6.5K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

2.6K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.6K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

163
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
163
The Two-State Receptor Model01:29

The Two-State Receptor Model

1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
1.9K
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Solvent Environment Influences Molecular Conformation and Electron Transport in Peptides.

The journal of physical chemistry letters·2026
Same author

Mapping Strigolactone Hydrolysis in DWARF14 via QM/MM String Method.

bioRxiv : the preprint server for biology·2026
Same author

Characterizing Defect Dynamics in Silicon Carbide Using Symmetry-Adapted Collective Variables and Machine Learning Interatomic Potentials.

Journal of chemical theory and computation·2026
Same author

De novo Folding Mechanisms of Lasso Peptides.

bioRxiv : the preprint server for biology·2026
Same author

Dynamic mechanism for subtype selectivity of endocannabinoids.

The Journal of biological chemistry·2026
Same author

Multiple modes of cholesterol translocation in the human Smoothened receptor.

eLife·2026

Related Experiment Video

Updated: Jun 7, 2025

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans
14:25

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans

Published on: September 21, 2019

7.3K

Dynamic Mechanism for Subtype Selectivity of Endocannabinoids.

Soumajit Dutta1, Lawrence Zhao2, Diwakar Shukla1,3,4,5

  • 1Department of Chemical and Biomolecular Engineering, University of Illinois at Urbana-Champaign, Urbana, IL, 61801.

Biorxiv : the Preprint Server for Biology
|November 18, 2024
PubMed
Summary

Endocannabinoids like anandamide show selectivity for CB1 receptors due to distinct binding pathways and pocket dynamics. This research clarifies mechanisms for developing targeted cannabinoid receptor drugs.

Keywords:
G-protein-coupled receptorMarkov state modelRelative binding free energy calculationVAMPnets subtype selectivityallosteric binding siteanandamidecannabinoid receptorsmolecular dynamics

More Related Videos

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

13.6K
Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
07:48

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis

Published on: July 3, 2015

8.7K

Related Experiment Videos

Last Updated: Jun 7, 2025

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans
14:25

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans

Published on: September 21, 2019

7.3K
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

13.6K
Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
07:48

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis

Published on: July 3, 2015

8.7K

Area of Science:

  • Biophysics
  • Computational Chemistry
  • Neuroscience

Background:

  • Endocannabinoids are endogenous ligands regulating bodily functions via cannabinoid receptors (CB1 and CB2).
  • Developing selective drugs targeting CB receptors is a significant research interest.
  • The biophysical basis for endocannabinoid subtype selectivity remains unclear.

Purpose of the Study:

  • To elucidate the mechanisms underlying anandamide's selectivity for the CB1 receptor.
  • To investigate the roles of ligand-protein interactions, binding pathways, and pocket dynamics in receptor selectivity.

Main Methods:

  • Extensive molecular dynamics simulations (0.9 milliseconds).
  • Markov state modeling and deep learning-based VAMP-nets for binding process analysis.
  • Relative free energy calculations for validating ligand-protein interactions.

Main Results:

  • Distinct N-terminus positions and lipid access channels influence anandamide binding mechanisms and interactions.
  • CB2 receptor's larger pocket volume enhances ligand fluctuations but reduces stable interactions (entropic effects).
  • CB1 selectivity is driven by dominant enthalpic contributions from stable ligand-protein interactions.

Conclusions:

  • Enthalpy-entropy balance differences between CB1 and CB2 receptors dictate endocannabinoid selectivity.
  • Anandamide's CB1 selectivity arises from favorable enthalpic interactions within a more constrained binding pose.
  • Findings provide insights for designing novel CB receptor-selective drugs.